The European Medicines Agency (EMA) is continuing to study reports of rare blood clot events potentially linked to the AstraZeneca vaccine, but said on Thursday that the jab “is safe and effective in preventing Covid-19”.
Following a review of the vaccine and reported rare incidents of blood clots among recipients, the EMA did not find a link to an overall risk of blood clotting, but will continue its investigations.
The regulator’s findings come after 13 EU member states halted their rollouts of the AstraZeneca vaccine, which the Anglo-Swedish pharmaceutical company developed with Oxford University.
Speaking at a press conference to discuss the agency’s review, EMA chief Emer Cooke said the regulator’s Pharmacovigilance Risk Assessment Committee had come to a “clear scientific conclusion” after reviewing reports of blood clotting.
Cooke added that despite days of in-depth analysis of numerous evidence, the EMA “still cannot rule out definitively” a link between cases of blood clotting and the vaccine.
The regulator has therefore recommended highlighting the possible risks in updated product information and will launch additional investigations and studies into blood clotting, she said.
“This is a safe and effective vaccine, its benefits in protecting people from Covid-19 with the associated risks of death and hospitalization outweigh the possible risks,” Cooke said.
The committee also concluded that the vaccine is not associated with an increase in the overall risk of thromboembolic events or blood clots.
Cooke did stress, however, that during the EMA probe and review, officials saw a “small number of cases of rare and unusual but very serious clotting disorders” that had led to a more focused review, which is underway.
About 7 million people have received the AstraZeneca vaccine in the EU and 11 million in the UK, and the jab is being rolled out in other countries.
The benefits of using the AstraZeneca vaccine “outweigh its risks”, the World Health Organization and the UK’s drugs regulator, the Medicines and Healthcare products Regulatory Agency, said in statements Thursday.
Think your friends would be interested? Share this story!
The European Medicines Agency (EMA) is continuing to study reports of rare blood clot events potentially linked to the AstraZeneca vaccine, but said on Thursday that the jab “is safe and effective in preventing Covid-19”. Read Full Article at RT.com Read More
Joe Biden delayed his remarks to the country twice this afternoon. The press conference was rescheduled to 4:30 PM Eastern but that was also delayed. In lieu of Joe Biden’s delayed press briefing, the White House releases a statement on “completing the mission.” Apparently, the Biden Regime feels their work in Afghanistan is near completion… […]
One year after the astounding US humiliation in Kabul – and on the verge of another serious comeuppance in Donbass – there is reason to believe Moscow is wary of Washington seeking vengeance: in the form of the ‘Afghanization’ of Ukraine. With no end in sight to western weapons and finance flowing into Kiev, it […]
Authored by Jim Quinn via The Burning Platform blog, “Do not be deceived: God cannot be mocked. A man reaps what he sows. The one who sows to please his sinful nature, from that nature will reap destruction; the one who sows to please the Spirit, from the Spirit will reap eternal life. Let us […]
